Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use INTUNIV® safely and effectively. See full prescribing information for INTUNIV. INTUNIV® (guanfacine) extended-release tablets, for oral useInitial U.S. Approval: 1986
Medication labelWhy this: Advisory · dailymed-prescription
INTUNIV® is indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) as monotherapy and as adjunctive therapy to stimulant medications [see Clinical Studies (14)].
- generic_name
- guanfacine
- product_names
- guanfacine
- ndc
- 54092-513, 54092-515, 54092-517, 54092-519, 54092-520, 54092-513-02, 54092-513-03, 54092-515-02, 54092-515-03, 54092-517-02, 54092-517-03, 54092-519-02, 54092-520-01
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en